Proton pump inhibitors and H2-receptor antagonists suppress gastric acid secretion and secondarily induce hypergastrinemia. Sustained hypergastrinemia has a trophic effect on stomach fundic mucosa. including enterochromaffin-like (ECL) cell hypertrophy and hyperplasia. Histomorphometric quantitation of the pharmacologic gastric effects was conducted on 10 male and 10 female rats treated orally with LY307630 sodium, a proton pump inhibitor, at daily doses of 25, 60, 130. or 300 mgkg for 3 mo. Histologic sections of glandular stomach, stained for chromogranin A. were evaluated by image analysis to determine stomach mucosal thickness, mucosal and nonmucosal (submucosa and muscularis) area, gastric glandular area. ECL cell numberlarea and cross-sectional area. Total mucosal and nonmucosal tissue volumes per animal were derived from glandular stomach volumetric and area data. Daily oral doses of compound LY307640 sodium caused slight to moderate dose-related mucosal hypertrophy and ECL cell hypenrophy and hyperplasia in all treatment groups as comparcd with controls. AU observed effects were prominent in both sexes but were generally greater in females. The morphometric sampling schemes were explored to optimize the data collection efficiency for future studies. A comparison between the sampling schemes used in this study and alternative schemes was conducted by estimating the probability of detecting a specific percentage of change between the male control and high-dose groups based on Tukey's trend test. The sampling scheme analysis indicated that mucosal thickness and mass had been oversampled. ECL cell density quantitation efficiency would have been increased by sampling the basal mucosa only for short-term studies. The ECL cell size sampling scheme was deemed appropriate for this type of study.
INTRODUCTION
Conventional wisdom suggests that HZreceptor antagonists (e.g., ranitidine, cimetidine) and proton pump (H+,K(+)-ATPase) inhibitors such as omeprazole suppress gastric acid secretion, which in tiim leads to increased production of gastrin. Sustained hypergastrinemia has a trophic effect on the fundic mucosa, resulting in enterochromaffin-like (ECL) cell hypertrophy and hyperplasia (5) . Lifetime exposures of rats to gastric acid suppressers has resulted in ECL cell proliferation, developing into focal hyperplasia and gastric carcinoids (1).
LY307640 is a proton pump inhibitor that is a potent suppresser of gastric acid secretion (8) . A 3-mo study was conducted to determine the subchronic effects of daily administration of LY307640 sodium to rats. A goal of the study was to quantitate gastric mucosal and ECL cell changes in the fundic portion of the rat stomach. The current morphometry study was designed to evaluate not only changes in mucosal thickness and ECL cell density, as has been the standard practice (2, 9, 12) but also to examine volumetric changes in the gastric mucosa and the nonmucosa (submucosa and muscularis) and treatment-related changes in ECL cell size.
Quantitation of morphometric parameters often requires evaluations of large numbers of animals to detect -subtle morphologic changes. It i s difficult to choose an optimum sampling scheme that ensures both a reasonable probability of detecting a morphologic change and an efficient data collection effort. In mammals, ECL cells occur predominately in the basal one-third to one-half of the mucosa (5) . Therefore, depending on the goal (precise estimate of the total number of ECL cells in the stomach or relative estimate for comparison across treatment groups), one could choose to sample only in the basal mucosa. Tuch et a1 (12) explored the merits of sampling full mucosal thickness versus basal mucosa for estimating ECL cell numberlarea in rats. Alternative sampling schemes for measuring parameters in the current study were evaluated in terms of the probability of detecting a change from control caused by treatment at the high dose.
Results of this sampling scheme analysis will be used to optimize data collection in future gastric studies. MATERIALS AND METHODS Study Design. Sprague-Dawley rats (SD/Tac, Taconic, Germantown, NY), 5-7 wk of age and 150-215 g (males) and 125-190 g (females), were housed individually in ventilated racks in a controlled environment (20.5-23.8"C, 30-70% relative humidity, 12 hr light). Purina Certified Rodent Chow No. 5002 and tap water were available for ad libitrim consumption. Animal housing and care were in accordance with USDA guidelines for humane care.
Ten male and 10 female rats were randomly assigned 403 At necropsy, the stomach and attached duodenum of each animal were excised, and the duodenum was clipped shut. The stomach was infused by gravity flow with phosphate-buffered zinc formalin at 75 cm pressure, the esophagus was clipped shut, and the stomach was then immersed in fixative for about 24 hr. Extraneous tissues and the duodenum were excised, the contents were rinsed out, and the whole stomach was weighed. The nonglandular portion of the stomach was excised by cutting along the limiting ridge, and the volume of the glandular stomach (corpus and antrum) was determined by fluid displacement (1 1). The glandular stomach was bisected along the greater and lesser curvatures, and 1 section of corpus including the limiting ridge was obtained from the midregion of each half of the glandular stomach for morphometric analysis. Histological specimens from the glandular stomach were embedded in paraffin and sectioned with a microtome to provide cross-sections of the full thickness of the glandular stomach. Sections were stained with chromogranin A (SP-1 rabbit anti-bovine, IncStar, Stillwater, MN; 1:200 dilution) and counterstained with hematoxylin.
hinge Analysis. Stomach mucosal thickness, mucosal and nonmucosal area (mucosa = lining epithelial cells, mL.jcularis mucosae, and lamina propria; nonmucosa = submucosa and muscularis externa), gastric glanduIar area, ECL cell numberhea, and ECL cell area profiles were quantitated on an image analyzer (Quantimet 570C@, Leica, Deerfield, IL). Analyzed images were recorded with a color camera (Sony CCDB, Sony Corp., Teaneck, NJ) attached to a light microscope (Leitz DMRXE@, Leica) equipped with X5, X40, and XlOO objectives. A systematic approach to field selection, independent of field content, was used. One fundus section per animal was evaluated. Specimens were analyzed in a nonblind design in a rotation of 1 specimenlsexldose to minimize operator bias.
Three QBasic macro programs were developed to permit semiautomated data collection. The first macro program was developed to measure mucosal thickness and mucosal and nonmucosal area ( Fig. 1 ). Mucosal thickness measurements were averaged by animal and dose group. Estimates of the total mucosal tissue volume by animal were determined by multiplying the ratio of the mucosal area to total gastric glandular area per field by the glandular stomach volume as determined previously by volumetric displacement. Nonmucosal tissue volume was included in the analysis following analysis of the mucosal volume and stomach weight data. The nonmucosal tissue volume was evaluated by first deriving the nonmucosal area by subtracting the mucosal area from the gastric glandular area per field. Then the nonmucosal tissue volume was calculated on a per animal basis as described for total mucosal tissue volume.
The second macro program determined the numbers of ECL cells/mm2 of mucosa ( Fig. 2) . Field location selection depended upon mucosal thickness. Whenever possible. 3 adjacent cross-sectional fields (base, neck, and gastric pit) from each of 2 evenly spaced locations were measured ( Fig. 2A ). On sections with thinner mucosae, 2 fields from each of 3 locations, approximately equally -3 FIG. I.-Diagram of rat glandular stomach with digitized image inserts. Glandular stomach is comprised of mucosal (M) and nonmucosal (Nhl) tissue. Mean mucosal thickness per animal (A) was determined by averaging 9 thickness measurements (dotted lines) acquired from 3 fieldslanimal using a X5 objective on a grayscale digitized image. The first field was located such that the edge of the field was centered over the fundus and just excluded the limiting ridge (LR). Fields 2 and 3 were located by moving exactly 1 field width laterally from the previous field. Specimens obviously sectioned obliquely were either reprocessed or excluded from the analysis. Mucosal and nonmucosal areas (B) were measured by drawing a line along the mucosalhonmucosal interface (black and white line). thresholding. and measuring the area of each part separately. Total glandular area was calculated on a per field basis by adding the mucosal and nonmucosal areas together. Only the mucosal and gastric glandular areas were recorded.
FIG . 2. -Diagram of rat glandular stomach and light microscopic image of chromogranin A-stained ECL cells. A) Sampling scheme when 3 fields were required, while B) Sampling scheme when only 2 fields were required to sample full thickness of mucosa. C) Light microscopy field of chromogranin A-stained ECL cells acquired with a X40 objective on a color digitized image. Stained ECL cells are indicated by arrowheads. Six fieldslanimal were measured. The initial field was selected by moving to a position approximately one-third or one-fourth (depending on mucosal thickness) the distance of the total length of [he section from the limiting ridge and just above the submucosa. The camera was rotated to align the long axis of the stomach section with the image frame. ECL cells within a field were selected on the basis of having a definable nucleus, which both diminished the bias in favor of large cells and reduced the "overcount" inherent with this methodology. The selected cells were counted on screen by manually marking each with a computer mouse. The computer summed the marks for each field. Mucosal area of the field was collected by thresholding and recording the thresholded area. The location of each'field within the mucosa (base, neck, or gastric pit region) was recorded to aid in the sampling scheme analysis. A replicate measurement for purposes of sampling scheme analysis was a column of 2 or 3 stacked fields encompassing the full thickness of [he mucosa.
FIG. 3.-Diagram of rat glandular stomach and light microscopic image (X 100 objective) of chromogranin A-stained ECL cells (A, arrowheads). One field in each of 3 layers within the mucosa was evaluated for each animal from a grayscale digitized image. The starting position A was approximately one-third the length of the section from the limiting ridge with the bottom edge of the field at the mucosa-submucosa boundary. Field B is 2 field widths directly above A and C is 2 field widths above B. The numbers of cells evaluated within the base, neck, and gastric pit areas were 4, 2, and 1, respectively. The count differential was selected to reflect the greater density of ECL cells in the base of the mucosa. Cells were selected for measurement by use of a line of random length, orientation, and position overlaid on the image. ECL cells with a clearly defined nucleus that touched the line were manually outlined on screen and measured. spaced within the section, were evaluated ( Fig. 2B) . ECL cell density throughout the full thickness of the mucosa was quantitated in such a manner that it was possible to analyze the effects of having sampled only in 1 particular layer of the mucosa (e.g., basal only). The mean number of ECL celldarea mm2 was determined by summing the number of ECL cells counted per animal and dividing by the sum of the mucosal field areas. The number of ECL cells per volume of gastric mucosa was estimated by converting the number per area (mm2) to number per volume (mm3) by dividing the mean number of ECL cells/area by the mean diameter of the ECL cells per animal (14). The mean diameter of the ECL cells per animal was determined using data collected with the third macro.
The third macro determined ECL cell size. The area and mean diameter of selected individual ECL cells were measured using a X 100 objective ( Fig. 3) . ECL cell areas were averaged by animal and by dose group, and the mean diameter of the ECL cells was used to estimate the number of ECL cells per volume of gastric mucosa.
Statistical Analysis. Statistical analyses for stomach weight (absolute and relative to body weight), mucosal and nonmucosal tissue volume, stomach mucosal thickness, mean individual ECL cell area, number of ECL cells per area of mucosa, and estimated portion of mucosa occupied by ECL cells were conducted on individual animal data. Treatment effects were evaluated separately for males and females using a l-way analysis of variance and sequential tests of linear treatment contrasts based on ordinal spacing of dose levels (13). All tests were completed at the nominal 0.05 significance level using the GLM procedure (10).
Sample Scheme Analysis. The question of whether animals had been optimally sampled with respect to the number of fields and number of replicate measurements within a field (as applicable) was examined. Four parameters were chosen for evaluation: mucosal tissue volume, mucosal thickness, ECL cell numeric density, and ECL cell size. The relative contributions to experimental error due to animal, field, and replicate variability were estimated from the data. Based upon the estimated variance components, the power of Tukey's trend test was determined by calculating the probability of detecting a significant linear trend in mean responses through the highdose treatment group for a specified percent change from the control group mean. Power curves for a range of high-dose percent changes were computed for the sampling scheme used in this study and for alternative schemes.
Power comparisons were not made for lower dose groups because the relative merits of the alternative schemes would be the same as those for the high-dose group. Variance components were comparable for males and females, and thus the relative power of alternative sampling schemes in male rats (Fig. 4) should be similar for females. Additionally, because the male mucosal and ECL cell changes were generally less prevalent than those in females, a sampling scheme based on changes observed for males would detect more subtle changes than 1 based on the responses for high-dose females. For the power analysis, a replicate for ECL density measure--. ments referred to a set of full mucosal thickness measurements. Depending on mucosal thickness, the number of replicate measurements for ECL cell density was either 3 (2 "stacked" fields X 3 locations) or 2 (3 "stacked" fields X 2 locations).
Two parameters, ECL cell density and ECL cell size, were additionally evaluated to determine the effects of limiting measurements to the basal mucosa only as opposed to full mucosal thickness sampling, as was done in the current study. For each animal, the number of ECL cells per area of mucosa was calculated first using measurements from all fields and then using measurements from fields in the basal mucosa only. Similarly, ECL cell size was determined using measurements from all fields and was compared with cell size means calculated using only fields from the basal mucosa. The impact of sampling only the basal mucosa was investigated by a multivariate analysis of full thickness and basal mucosal measurements, with separate analyses for ECL cell density and ECL cell size.
RESULTS

Treatinelit Resiilts
Compound LY307640 sodium, administered to rats for 3 mo, resulted in increased stomach weights, increased gastric mucosal thickness, ECL cell hypertrophy (increased size), and ECL cell hyperplasia (increased number) in all treatment groups. Effects were prominent in both sexes but were generally more evident in females than in males. All treatment-related effects tended to be dose responsive. Increases were generally prominent between control and low-dose 125 mgkg) rats, but the degree of additional increase for each succeeding dose was usually smaller.
Stomach weight increases were consistent with increases in glandular stomach and mucosal and nonmucosal tissue volumes and increases in mucosal thickness. Dose-related increases in absolute and relative (to body weight) stomach weights of males and females ranged from 13% to 70% when compared with those of controls. Comparable increases were noted for mucosal volumes (Table I) .
The glandular (mucosa plus underlying nonmucosal tissues) stomach volume increased at approximately the same rate as the mucosal tissue alone (Table I) . Evaluation of nonmucosal tissue showed increases of 0-43%, comparable to although slightly lower than the increased stomach weights. Equally prominent were increases in the mean thickness of the mucosa. Thus, the increases in stomach weight and glandular stomach volume were gen-.erally due to proportional increases in both the mucosal and the nonmucosal components of the stomach.
A significant sex by treatment interaction (p C 0.001) was present for mucosal thickness, ECL cell number, ECL cell area, and total ECL cell volume as a percentage of mucosa, indicating that the dose response for treatment was different for males than for females (Tables I and  11 ). The greatest increases occurred in mean total ECL cell volume as a percentage of mucosa and mean ECL cell numbers per area (18-and 9-fold, respectively) for 300 mgkg dose group females as compared with controls. An average 2-fold increase was observed for mucosal thickness and ECL cell area when comparing 300 mgkg treated rats with control rats.
Statistical Analysis of Sampling Scheme f o r Power in Detecting Treatment Efsects
The relative contributions of animal, field, and replicate error (as applicable) to the total variance of mucosal tissue volume, mucosal thickness, and ECL cell density are summarized in Table 111 . For ECL cell size, 2 variance estimates are provided for an animal mean response. The first estimate was based on all measurements (4:2:1 proportionate sampling), and the other was based only on basal mucosal measurements.
Power curves for male rats based on the variance estimates in Table I11 are plotted in Fig. 4 . All power calculations were based on untransformed data. Distributional assumptions were investigated for each parameter, and results showed that the power for detecting treatment effects on ECL cell density could be increased by analysis of log-transformed data. Use of the transformation did not alter the relative impact of changes in sampling scheme. No improvement in power was evident by transformation of other parameter values.
-.
Power estimates (Fig. 4a, b) indicated an oversampling for mucosal tissue volume and mucosal thickness. Variation in tissue volume was dominated by differences among rats (93% of total), indicating little power would have been lost by measurement of a single field. A greater loss of power would be expected if the number of mucosal thickness measurements was reduced, particularly if only one field was selected. Using 0.80 as the required power for a study, 2 fields per animal and a single thickness measurement per field would have been sufficient to detect the differences among treatment groups observed in this study.
The ECL cell density power curves for the current study (full thickness sampling scheme) indicated a small loss of power would be expected if the number of replicates (locations) were reduced from 3 to 2 (Fig. 4c ). An even greater loss would have resulted with only 1 replicate, but a single full thickness set of measurements per animal would have been sufficient to detect the change in ECL cell density observed in this study (power >0.80).
Although the mean ECL cell densities for full thickness (=) and basal (B) sampling schemes were significantly different from each other, both schemes resulted in all treatment groups being significantly different from the controls by Tukey's trend test (Table 11 ). Multivariate analysis of measurements from both schemes revealed no significant difference in linear trends for males but significantly different linear trends for females. This result was primarily due to a decrease in B cell density between the 130 mg/kg and 300 mgkg dose groups as compared with an increase in FT cell density between the same 2 dose groups. Assuming both schemes were valid, the power to detect the same relative change from controls was greater for B sampling with 3 replicates than for FT sampling (Fig. 4c) . Absolute values and linear trends in mean ECL cell sizes for FT and B sampling were similar; however, only the FT sampling scheme demonstrated significant differences (p < 0.05) from controls for all treatment groups in both sexes ( Table 11 ). The B sampling scheme did not demonstrate a significant difference from control for males (p = 0.06) for any treatment group. The reason for the difference was less variability in ECL cell size values with the FT sampling scheme than with the B scheme.
However, no correlation was found between cell size and location in the mucosa. The loss of power expected with the use of B only measurements was given by the vertical difference between the upper and lower curves in Fig.   4d . The middle curve provided an estimate of the expected power if 4 additional cells were measured in a second B field. A power of 0.80 for the percent change observed in this study was achieved only when using the l T sampling scheme.
DISCUSS~ON
Morphometry was used in the current study to demonstrate the trophic effects expected to be caused by hypergastrinemia associated with LY307640. Secondarily, sampling schemes were explored to maximize data collection efficiency for future studies.
Hypergastrinemia is promoted by inhibitors of gastric acid secretion (proton pump inhibitors and HZreceptor antagonists). The trophic effects of these agents include .gastric mucosal thickening' and ECL cell hyperplasia in rat stomachs (2, 3) . The techniques employed in the current study provide results indicating, for each of the parameters studied, a very clear treatment response, which was less prominent with increasing doses.
Administration of LY307640 sodium resulted in mucosal thickening and ECL hyperplasia in rats. These changes were expected and have been widely reported for antisecretory agents that induce hypergastrinemia. The slightly greater response, particularly in ECL cell hyperplasia, of females as compared with males -was also expected. A similar sex difference was noted for the proton pump inhibitor omeprazole when administered to rats for 2 yr (6). In addition, gastric carcinoid tumors, which are secondary to sustained hypergastrinemia in rats, were more prevalent in female than male rats in chronic studies with omeprazole (3). In the present study, it is possible that the greater gastric morphometric response of female rats to compound LY307640 sodium is due to the slightly greater uptake of this compound observed for females as determined from blood level absorption analysis (Lilly Research Laboratories, unpublished).
The established gastric parameters for evaluation of compounds affecting the gastric mucosa have been limited to mucosal thickness and ECL cell density (7, 9, 12) . Although these parameters are important, they may be more subject to artifacts of tissue collection methods than volumetric measurements and do not allow for the evaluation of other stomach components such as the supporting tissues (e.g., nonmucosa). In the current study, mucosal and nonmucosal tissue volume changes and ECL cell size were also evaluated.
Examining additional parameters minimizes the effects of processing artifacts. For instance, if not pinned flat or infused consistently, the mucosa tends to fold in on itself, which introduces more variability into the thickness measurements. Converting area measurements to volumetric measurements by taking into the account the stomach : body weight ratio and percent gastric mucosa (of total gastric area) decreases the influence of processing artifacts, as our results show. The results from mucosal thickness and mucosal volume measurements were similar with the important exception that mucosal volume was significantly increased in the low-dose male treatment group, a result not identified in the analysis for mucosal thickness in the same group.
Increases in the volume of nonmucosal tissues were somewhat unexpected; previous authors had not reported measurements of these components. Data for the non-mucosal tissue increases were examined only after noting the nearly identical rate of increases in glandular stomach volume, as measured by volumetric displacement, and mucosal tissue volume. This increase strongly suggested that the nonmucosal tissue volume must also be increased along with the expected increase in mucosal volume. The increase in nonmucosal tissue may be a compensatory response to support the increase in mucosal tissue.
The specific effects of gastric antisecretory agents on the size of ECL cells seldom has been addressed. This omission makes it difficult to determine if observed increases in ECL density are due to increased numbers (hyperplasia) or size (hypertrophy) or both. ECL cells are commonly quantitated either by determining numerical cell density or by determining the ratio of total ECL chromogranin A-stained area to mucosal area. Neither method measures individual ECL cell sizes. In this study, the area profiles for randomly selected individual ECL cells were measured. A clear increase in ECL cell size was demonstrated for all treatment groups. Our findings are consistent with those of Hakanson et a1 (3, who found that ECL cell hypertrophy is the initial response to sustained gastrin stimulus. The hypertrophy occurred within days, whereas the more commonly reported ECL cell hyperplasia did not develop in the rat until weeks to months later. The current study demonstrates that the ECL hypertrophy is sustained over time.
Sampling methods were evaluated to determine if the same results could be obtained more efficiently. We explored both the questions of sampling fewer animals and of sampling fewer fields per animal for each of the parameters measured. Sampling fewer animals was quickly dismissed because the greatest --source of variability (error) in this study was between rats. This conclusion is supported by the conventional wisdom in morphometry that it is better to "do more less well" (4).
The question remained as to whether gastric tissue specimens from individual animals had been optimally sampled. The results were mixed. The analysis indicated that nearly identical results for 2 of the 4 parameters, mucosal tissue volume and mucosal thickness, would have been obtained with only 1 measurement on each of 2 rather than 3 fields/stomach. The variability between replicate measurements within and between fields on the same individual was smaller than expected. Retrospectively, the small variability is not surprising, because the mucosal parameter measurements were acquired at relatively low magnification, X5, and extra care was taken in sample preparation (each stomach was infused). However, the sampling scheme for ECL cell density or size was appropriate and the number of replicates should not be' reduced.
With regard to ECL cell density, the question still remained as to whether it was necessary to sample the full thickness of mucosa; the majority of the ECL cells reside in the basal mucosa. ECL cell density was determined in the present study by counting cells in adjacent "stacked" fields, which represented the entire thickness of the mucosa. This approach provided a more precise estimate of the ECL cell numerical density than the alternative approach of sampling only in the basal mucosa. Was the more precise FT method necessary to establish treatmentrelated ECL cell hyperplasia? For this 3-mo study, the answer is "no." The B sampling scheme would have achieved the same results in the current study with less effort. In fact, the power analysis showed that the probability of detecting the same relative change from control is greater for B sampling with 3 replicates than for FT sampling. Our findings were consistent with those of Tuch et a1 (12), who reported that the relative ECL cell density for the basal mucosa was more sensitive in demonstrating drug effect. However, caution is needed when applying these findings to longer studies. Full thickness ECL cell density counts were superior in a subsequent 6mo rat study with the same compound. An unexpected shift in ECL cell concentration from the base to the neck of the mucosa was observed in males administered 30 and 60 mgkg of compound for 6 mo (S. L. White, unpublished). Consequently, B sampling only would have resulted in an underestimation of ECL cell density in the 6-mo study.
A comparison of FT versus B sampling schemes for ECL cell size determined that for the present study F T was the better method. ECL cell size differed greatly, although there was no correlation between cell size and location in the mucosa (base, neck, or gastric pit). Seven cells per animal were measured of which 4 cell measurements were from the basal mucosa. The number of cells measured was adequate to show ECL cell hypertrophy, however more fields would have been required to demonstrate a less dramatic increase with the current FT sampling scheme. For longer studies, limiting the sampling to the basal mucosa only is not supported, especially when considering the anticipated increase in sample Variability.
The observed morphometric effects (mucosal thickening and ECL cell hypertrophy and hyperplasia) of subchronic administration of LY307640 sodium at 25-300 mgkg are consistent with reported findings for rats exposed to proton pump inhibitors and HZreceptor antagonists. The morphometric findings from the current nonblind study support the hypothesis that the pharmacological response (gastric acid secretion suppression, hypergastrinemia, ECL cell hyperplasia) in rats dosed with LY307640 sodium was expected for this class of compounds. The slightly greater response in females with regard to ECL cell hyperplasia and hypertrophy has also been previously reported and in the current study may be associated with higher compound absorption rates in females. The techniques employed in the current study provided results indicating for each of the parameters studied a very clear treatment response, which was less promi--. . than would have been required to demonstrate the 01 served changes. The number of fields and replicate me; surements per field could have been reduced for mucosa nonmucosal tissue area and mucosal thickness measurt ments because the greatest source of variability in th data was between animals. Sampling the full thickness c the mucosa was more sensitive than sampling only th basal mucosa for the determination of ECL cell size however, basal only sampling was a more sensitive ap proach for detecting changes in ECL cell density over thc course of the 3-mo study.
